By analyzing publicly available, large neuroblastoma patient cohorts, we presented DHODH expression as an independent prognostic marker in neuroblastoma after adjusting for known adverse factors, such as disease stage, age, and MYCN amplification. The gene discussed is MYCN; the disease is neuroblastoma.